Can a 4 mm kidney stone pass through the ureters?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a 4 mm Kidney Stone Pass Through the Ureters?

Yes, a 4 mm ureteral stone has a high likelihood of spontaneous passage (approximately 81% within 20 weeks), and observation with or without medical expulsive therapy should be offered as first-line management in patients with controlled symptoms. 1, 2

Spontaneous Passage Rates by Stone Size

The evidence clearly demonstrates that stone size is the strongest predictor of spontaneous passage:

  • Stones ≤5 mm: Approximately 68% spontaneous passage rate (95% CI: 46-85%) 1
  • 4 mm stones specifically: 81% spontaneous passage rate within 20 weeks 2
  • Stones >5 mm but ≤10 mm: 47% spontaneous passage rate (95% CI: 36-59%) 1
  • Stones >10 mm: Unlikely to pass spontaneously and typically require surgical intervention 1

Initial Management Approach

For uncomplicated 4 mm ureteral stones, observation with or without medical expulsive therapy (MET) using alpha-blockers is appropriate as initial management. 3, 1

Prerequisites for Conservative Management:

  • Well-controlled pain 3
  • No clinical evidence of sepsis 3
  • Adequate renal functional reserve 3
  • No anatomical abnormalities complicating passage 4

Medical Expulsive Therapy:

  • Alpha-blockers increase stone passage rates by approximately 29% compared to control (95% CI: 20-37%) 1
  • Patients must be counseled about off-label use and potential side effects 3

Time Frame and Monitoring

Conservative therapy should be limited to a maximum of 6 weeks from initial presentation to avoid irreversible kidney injury. 3, 1

Expected Passage Timeline:

  • For stones 2-4 mm: Average time to passage is 12.2 days 5
  • For 95% of stones 2-4 mm to pass: Up to 40 days may be required 5

Required Monitoring:

  • Periodic imaging studies to monitor stone position 3
  • Assessment for hydronephrosis 3
  • CT scan is superior to ultrasound for accurate stone size determination 4, 1

Factors Affecting Passage Success

Beyond size, several factors influence spontaneous passage rates 2, 5:

  • Location: Distal ureteral stones have higher passage rates than proximal stones 1, 5
  • Side: Right-sided stones pass more readily than left-sided 5
  • Hydronephrosis severity: Severe hydronephrosis predicts lower passage rates 6
  • Inflammatory markers: Neutrophil-to-lymphocyte ratio ≥3.14 correlates with retained stones 6

When to Intervene

Surgical intervention (ureteroscopy or shock wave lithotripsy) should be offered if: 3

  • Stone fails to pass after 6 weeks of observation 3, 1
  • Intractable pain despite adequate analgesia 4
  • Evidence of urinary tract infection with obstruction 3, 4
  • Progressive or severe hydronephrosis 3
  • Patient preference for definitive treatment 3

Common Pitfalls

  • Underestimating passage time: While average passage is ~12 days, some 4 mm stones may take up to 40 days 5
  • Inadequate follow-up: Failure to monitor with periodic imaging can miss complications like progressive hydronephrosis 3
  • Ignoring infection: Untreated bacteriuria with obstruction can lead to urosepsis 3
  • Prolonged conservative management: Exceeding 6 weeks risks irreversible kidney damage 3, 1

Special Populations

Pediatric Patients:

  • Observation with or without MET is appropriate for stones ≤10 mm 3
  • Stone-free rates of 62% for stones <5 mm in distal ureter 3, 1

Pregnant Patients:

  • Observation is first-line therapy with well-controlled symptoms 3
  • Spontaneous passage rates similar to non-pregnant patients 3
  • Coordinate any intervention with obstetrics 3

References

Guideline

Kidney Stone Size and Spontaneous Passage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Nonobstructing Renal Calculi

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.